SCHEMBL5071364

SCHEMBL5071364

[CH2]C1C=CC=CC1(C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2746231 0.74
SCHEMBL5378825 0.72
SCHEMBL283912 0.72
SCHEMBL8123470 0.70
SCHEMBL3589631 0.70
SCHEMBL22791820 0.70
SCHEMBL7905677 0.70
SCHEMBL7958294 0.70
SCHEMBL3062309 0.68
SCHEMBL10424750 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131656-A2 PHTHALAZINE DERIVATIVES Forest Laboratories Holdings Limited (BM) 2009-12-16 EP claimed
WO-2008061108-A2 PHTHALAZINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO claimed
US-4552888-A Ascorbic acid ethers in angiogene ELI LILLY AND COMPANY (US) 1985-11-12 US disclosed
EP-0086554-A1 Ascorbic acid ethers and related compounds ELI LILLY AND COMPANY (US) 1983-08-24 EP disclosed